1. Home
  2. TVTX vs FBNC Comparison

TVTX vs FBNC Comparison

Compare TVTX & FBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • FBNC
  • Stock Information
  • Founded
  • TVTX 2008
  • FBNC 1934
  • Country
  • TVTX United States
  • FBNC United States
  • Employees
  • TVTX N/A
  • FBNC N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • FBNC Major Banks
  • Sector
  • TVTX Health Care
  • FBNC Finance
  • Exchange
  • TVTX Nasdaq
  • FBNC Nasdaq
  • Market Cap
  • TVTX 1.6B
  • FBNC 1.7B
  • IPO Year
  • TVTX N/A
  • FBNC N/A
  • Fundamental
  • Price
  • TVTX $17.49
  • FBNC $46.99
  • Analyst Decision
  • TVTX Buy
  • FBNC Buy
  • Analyst Count
  • TVTX 13
  • FBNC 1
  • Target Price
  • TVTX $23.46
  • FBNC $56.00
  • AVG Volume (30 Days)
  • TVTX 1.1M
  • FBNC 192.8K
  • Earning Date
  • TVTX 02-13-2025
  • FBNC 01-22-2025
  • Dividend Yield
  • TVTX N/A
  • FBNC 1.85%
  • EPS Growth
  • TVTX N/A
  • FBNC N/A
  • EPS
  • TVTX N/A
  • FBNC 2.48
  • Revenue
  • TVTX $203,447,000.00
  • FBNC $362,644,000.00
  • Revenue This Year
  • TVTX $62.17
  • FBNC N/A
  • Revenue Next Year
  • TVTX $56.38
  • FBNC $9.87
  • P/E Ratio
  • TVTX N/A
  • FBNC $19.10
  • Revenue Growth
  • TVTX 57.08
  • FBNC N/A
  • 52 Week Low
  • TVTX $5.12
  • FBNC $29.53
  • 52 Week High
  • TVTX $20.33
  • FBNC $50.34
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 39.02
  • FBNC 54.75
  • Support Level
  • TVTX $17.27
  • FBNC $47.06
  • Resistance Level
  • TVTX $19.20
  • FBNC $48.18
  • Average True Range (ATR)
  • TVTX 0.72
  • FBNC 0.99
  • MACD
  • TVTX -0.29
  • FBNC -0.20
  • Stochastic Oscillator
  • TVTX 3.80
  • FBNC 39.88

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

About FBNC First Bancorp

First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing, and investment advisory services.

Share on Social Networks: